Emerging translational approaches to target STAT3 signalling and its impact on vascular disease
about
Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular diseaseOncostatin M receptor β deficiency attenuates atherogenesis by inhibiting JAK2/STAT3 signaling in macrophages.The platelet-derived growth factor receptor/STAT3 signaling pathway regulates the phenotypic transition of corpus cavernosum smooth muscle in ratsInhibition of STAT3 activity delays obesity-induced thyroid carcinogenesis in a mouse model.Inhibition of STAT3 signaling blocks obesity-induced mammary hyperplasia in a mouse model.Plumericin inhibits proliferation of vascular smooth muscle cells by blocking STAT3 signaling via S-glutathionylation.Differential effects of IL-6 blockade tocilizumab and TNF inhibitors on angiogenesis in synovial tissues from patients with rheumatoid arthritis.The effects of signal transducer and activator of transcription three mutations on human platelets.The roles of signal transducer and activator of transcription factor 3 in tumor angiogenesis.Tofacitinib improves atherosclerosis despite up-regulating serum cholesterol in patients with active rheumatoid arthritis: a cohort study.Gastrin-releasing peptide promotes the migration of vascular smooth muscle cells through upregulation of matrix metalloproteinase-2 and -9.Genetic Interference With Endothelial PPAR-γ (Peroxisome Proliferator-Activated Receptor-γ) Augments Effects of Angiotensin II While Impairing Responses to Angiotensin 1-7.MicroRNA-146b-3p regulates the development and progression of cerebral infarction with diabetes through RAF1/P38MAPK/COX-2 signaling pathway.Genome-Wide Inhibition of Pro-atherogenic Gene Expression by Multi-STAT Targeting Compounds as a Novel Treatment Strategy of CVDsAnti-JNK2 peptide-siRNA nanostructures improve plaque endothelium and reduce thrombotic risk in atherosclerotic mice
P2860
Q26750725-DB3EFCDC-653F-4916-8A30-92E7259C3454Q33613358-CDD5AD94-3407-4B98-999F-34888F09A6ABQ36292972-F48AD7DE-CDF6-4BCD-A2E7-FC539BB27D87Q36351206-906F8864-5F0E-4009-8E35-BAE94F1121FAQ37743533-0E04ECFD-140F-4899-94AF-66F4DF524CB7Q38302272-A261AF05-0870-4780-8F9C-F060B6DD38AEQ39185901-82A60906-5DA9-425E-92E6-0E7A8350CC36Q41993160-1C57EF9C-7F14-48F2-8145-04293C33F9B4Q42366665-64EF563D-8267-4A87-B5D7-5694C5E1F96EQ42696887-B2D0A663-4854-4C74-B238-05334212BC4EQ47609299-865A81A2-9A36-48C5-9E21-9127810060C9Q47710820-A692C7B0-1D5F-497D-8530-A6B24F73786EQ55089831-C09E74EE-F24A-4F58-941E-AC2D0FE96AB1Q57072670-C170A571-20F0-4D7D-B68A-A26CA3904E9EQ58761484-118E0E3F-E369-4C81-B1D3-9C8198F00CAF
P2860
Emerging translational approaches to target STAT3 signalling and its impact on vascular disease
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Emerging translational approac ...... its impact on vascular disease
@ast
Emerging translational approac ...... its impact on vascular disease
@en
type
label
Emerging translational approac ...... its impact on vascular disease
@ast
Emerging translational approac ...... its impact on vascular disease
@en
prefLabel
Emerging translational approac ...... its impact on vascular disease
@ast
Emerging translational approac ...... its impact on vascular disease
@en
P2093
P2860
P921
P356
P1476
Emerging translational approac ...... its impact on vascular disease
@en
P2093
Daniel G Sedding
Jan-Marcus Daniel
Jochen Dutzmann
Johann Bauersachs
P2860
P304
P356
10.1093/CVR/CVV103
P5008
P577
2015-03-17T00:00:00Z
2015-06-01T00:00:00Z